Evidence map›Paper›PMID 30841934›Full record

ReviewParticle and fibre toxicology2019

Health effects of particulate matter air pollution in underground railway systems - a critical review of the evidence.

Matthew Loxham, Mark J Nieuwenhuijsen

Open access · goldAbstract readReview
In one paragraph

Review in Particle and fibre toxicology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 130 citations in OpenAlex.

  1. Article
  2. Air pollution and alveolar health.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  3. Article
  4. Assessment of air quality in the Philadelphia, Pennsylvania subway.Journal of exposure science & environmental epidemiology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Urban Particulate Matter Triggers Meibomian Gland Dysfunction.Investigative ophthalmology & visual science · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Topical Porphyrin Antioxidant Protects Against Ocular Surface Pathology in a Novel Rabbit Model for Particulate Matter-Induced Dry Eye Disease.Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Matthew LoxhamAcademic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Mailpoint 888, Level F, University Hospital Southampton, Tremona Road, Southampton, SO16 6YD, UK. m.loxham@soton.ac.uk.ORCID 0000-0001-6459-538X
Mark J NieuwenhuijsenISGlobal, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
Southampton General Hospital · GBUniversitat Pompeu Fabra · ES

Funding

Biotechnology and Biological Sciences Research Council BB/P011365/1
6 · The paper itself

Abstract

backgroundExposure to ambient airborne particulate matter is a major risk factor for mortality and morbidity, associated with asthma, lung cancer, heart disease, myocardial infarction, and stroke, and more recently type 2 diabetes, dementia and loss of cognitive function. Less is understood about differential effects of particulate matter from different sources. Underground railways are used by millions of people on a daily basis in many cities. Poor air exchange with the outside environment means that underground railways often have an unusually high concentration of airborne particulate matter, while a high degree of railway-associated mechanical activity produces particulate matter which is physicochemically highly distinct from ambient particulate matter. The implications of this for the health of exposed commuters and employees is unclear. MAIN BODY: A literature search found 27 publications directly assessing the potential health effects of underground particulate matter, including in vivo exposure studies, in vitro toxicology studies, and studies of particulate matter which might be similar to that found in underground railways. The methodology, findings, and conclusions of these studies were reviewed in depth, along with further publications directly relevant to the initial search results. In vitro studies suggest that underground particulate matter may be more toxic than exposure to ambient/urban particulate matter, especially in terms of endpoints related to reactive oxygen species generation and oxidative stress. This appears to be predominantly a result of the metal-rich nature of underground particulate matter, which is suggestive of increased health risks. However, while there are measureable effects on a variety of endpoints following exposure in vivo, there is a lack of evidence for these effects being clinically significant as may be implied by the in vitro evidence.

conclusionThere is little direct evidence that underground railway particulate matter exposure is more harmful than ambient particulate matter exposure. This may be due to disparities between in vivo exposures and in vitro models, and differences in exposure doses, as well as statistical under powering of in vivo studies of chronic exposure. Future research should focus on outcomes of chronic in vivo exposure, as well as further work to understand mechanisms and potential biomarkers of exposure.

Indexed as

Inhalation ExposureAir PollutantsAnimalsCell LineHumansLungMetalsParticle SizeParticulate MatterRailroadsRisk AssessmentToxicity TestsAir PollutantsMetalsParticulate MatterInflammationIronOxidative stressParticulate matterReactive oxygen speciesSteelSubwayTransition metalUnderground railway

Identifiers

PMID30841934
PMCPMC6404319
OpenAlexW2930590977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.